Skip to main content
Premium Trial:

Request an Annual Quote

Sequenom Sells MassArray System to Customers in Europe, Asia

NEW YORK, March 27 - Sequenom said Tuesday it has delivered MassArray systems for high-throughput SNP analysis to three new international customers: HiberGen of Wickow, Ireland; Korea Advanced Institute of Science and Technology (KAIST); and the National Cancer Center Research Institute in Japan.

"Our systems business continues to see demand for the MassArray platform, supported by influential early adopters such as the Sanger Centre, the Whitehead Institute and the National Institutes of Health," said Toni Schuh, Sequenom's CEO.

Sequenom said in a statement that it also sold a fourth system, although it did not disclose the name of the buyer.

Sequenom did not say how much the systems sold for, but in the past the company has said that the price of the MassArray is between $400,000 and $1.1 million depending on consumables.

In 2000, Sequenom placed 22 MassArray systems in seven different countries. So far this year, Sequenom has reported the sale of six systems.

HiberGen is a population genetics company that performs genotyping studies on the Irish population using its SNaPIT SNP analysis platform. KAIST and the National Cancer Research Institute are both publicly-funded research institutions performing genomics research.

The MassArray system, first commercialized in early 2000, provides a platform for genotyping experiments without the use of fluorescence or other tagging techniques. Instead, the company's technology applies MALDI-TOF mass spectrometry directly to fragments of DNA to detect SNPs.

The Scan

Guidelines for Ancient DNA Work

More than two dozen researchers have developed new ethical guidelines for conducting ancient DNA research, which they present in Nature.

And Cleared

A UK regulator has cleared former UK Prime Minister David Cameron in concerns he should have registered as a consultant-lobbyist for his work with Illumina, according to the Financial Times.

Suit Over Allegations

The Boston Globe reports that David Sabatini, who was placed on leave from MIT after allegations of sexual harassment, is suing his accuser, the Whitehead Institute, and the institute's director.

Nature Papers on Esophageal Cancer, Origin of Modern Horses, Exome Sequencing of UK Biobank Participants

In Nature this week: genetic and environmental influences of esophageal cancer, domestic horse origin traced to Western Eurasian steppes, and more.